# Tesamorelin in type 2 diabetes: 12-week blood sugar trial

Source: https://pepvault.app/research/tesamorelin-clemmons-2017

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Tesamorelin](https://pepvault.app/research#tesamorelin)

Randomized trial · people

# Tesamorelin: no change in glucose control in type 2 diabetes

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In people with type 2 diabetes, 12 weeks of tesamorelin did not change insulin response or blood sugar control compared with placebo.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 53
- **Published:** 2017
- **Journal:** PLoS One

## What they tested

The team tested whether tesamorelin changes insulin sensitivity or blood sugar control in people with type 2 diabetes.

## How the study was done

A randomized, placebo-controlled trial at several centers in 53 patients with type 2 diabetes, run for 12 weeks. Patients got placebo (a dummy treatment), 1 mg tesamorelin or 2 mg tesamorelin.

<!--promo-->

PepVault for iPhone

## Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

The main outcome was relative insulin response after drinking glucose. It did not differ significantly between the groups over 12 weeks. At week 12, fasting glucose, HbA1c (a measure of average blood sugar over the past few months) and overall diabetes control were also not significantly different, and changes to diabetes medicines were similar across groups. In the 2 mg arm, total cholesterol fell by 0.3±0.6 mmol/L and non-HDL cholesterol by 0.3±0.5 mmol/L from baseline, a significant drop compared with placebo (p<0.05), and no patient left the study because of losing diabetes control.

## What it doesn’t show

The trial was small and lasted only 12 weeks, so it does not show longer-term effects on blood sugar. It included only people with type 2 diabetes.

## The paper

Clemmons et al. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial. PLoS One. 2017.

- [PubMed (PMID 28617838)](https://pubmed.ncbi.nlm.nih.gov/28617838/)
- [The paper (DOI 10.1371/journal.pone.0179538)](https://doi.org/10.1371/journal.pone.0179538)
- [ClinicalTrials.gov (NCT01264497)](https://clinicaltrials.gov/study/NCT01264497)

## The compound

- [Tesamorelin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/tesamorelin)
- [Tesamorelin dose guide](https://pepvault.app/lab/dosage/tesamorelin)

## With this study

### Tesamorelin

- [Tesamorelin: the full reference](https://pepvault.app/peptides/tesamorelin)
- [Tesamorelin dose guide](https://pepvault.app/lab/dosage/tesamorelin)

### Mixing charts

- [2 mg vial](https://pepvault.app/tools/reconstitution-calculator/tesamorelin-2mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tesamorelin-10mg)

### Studies

- [Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy](https://pepvault.app/research/tesamorelin-badran-2026)
- [Tesamorelin shifted liver gene activity in HIV-related fatty liver](https://pepvault.app/research/tesamorelin-fourman-2020)
- [Tesamorelin: denser, larger trunk muscles at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-adrian-2019)
- [All 12 studies](https://pepvault.app/research#tesamorelin)

### Compared with

- [Sermorelin vs Tesamorelin](https://pepvault.app/peptides/compare/sermorelin-vs-tesamorelin)
- [Ipamorelin vs Tesamorelin](https://pepvault.app/peptides/compare/ipamorelin-vs-tesamorelin)
- [HGH vs Tesamorelin](https://pepvault.app/peptides/compare/hgh-vs-tesamorelin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Tesamorelin

- [Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy](https://pepvault.app/research/tesamorelin-badran-2026) Meta-analysis · people · 2026
- [Tesamorelin shifted liver gene activity in HIV-related fatty liver](https://pepvault.app/research/tesamorelin-fourman-2020) Randomized trial · people · 2020
- [Tesamorelin: denser, larger trunk muscles at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-adrian-2019) Randomized trial · people · 2019
- [Tesamorelin cut visceral and liver fat over 6 months in HIV patients](https://pepvault.app/research/tesamorelin-stanley-2014) Randomized trial · people · 2014
- [Tesamorelin had little effect on simvastatin and ritonavir levels](https://pepvault.app/research/tesamorelin-teng-2013) Randomized trial · people · 2013
- [Tesamorelin cut visceral fat 15.4% vs placebo in HIV at 26 weeks](https://pepvault.app/research/tesamorelin-falutz-2010) Randomized trial · people · 2010
- [Every study on Tesamorelin](https://pepvault.app/research#tesamorelin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Tesamorelin

- [Tesamorelin: the full reference](https://pepvault.app/peptides/tesamorelin)
- [Tesamorelin dose guide](https://pepvault.app/lab/dosage/tesamorelin)

### Mixing charts

- [2 mg vial](https://pepvault.app/tools/reconstitution-calculator/tesamorelin-2mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tesamorelin-10mg)

### Studies

- [Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy](https://pepvault.app/research/tesamorelin-badran-2026)
- [Tesamorelin shifted liver gene activity in HIV-related fatty liver](https://pepvault.app/research/tesamorelin-fourman-2020)
- [Tesamorelin: denser, larger trunk muscles at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-adrian-2019)
- [All 12 studies](https://pepvault.app/research#tesamorelin)

### Compared with

- [Sermorelin vs Tesamorelin](https://pepvault.app/peptides/compare/sermorelin-vs-tesamorelin)
- [Ipamorelin vs Tesamorelin](https://pepvault.app/peptides/compare/ipamorelin-vs-tesamorelin)
- [HGH vs Tesamorelin](https://pepvault.app/peptides/compare/hgh-vs-tesamorelin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Tesamorelin](https://pepvault.app/research#tesamorelin)

## The library

- [Tesamorelin](https://pepvault.app/peptides/tesamorelin)
- [Tesamorelin dose guide](https://pepvault.app/lab/dosage/tesamorelin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
